Vitanova Life Sciences's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Vitanova Life Sciences (VNOV) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Vitanova Life Sciences vs Its Competitors
- TTM: Trailing 12-month revenue of 3M vs -M combined for its competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-60.3% annualized vs trailing 12 months).
- Peer revenue share: Vitanova Life Sciences accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
- Structure: Vitanova Life Sciences operates in the following segments: Dietary Supplement Segment, Food Products, Other.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
VNOV Sales vs. its Competitors, Q1 2026
Vitanova Life Sciences generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
API endpoints for this dataset
For context: the Apparel, Footwear & Accessories industry grew revenue 8.3% year over year, combined, vs 209.5% for Vitanova Life Sciences. Vitanova Life Sciences's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
VNOV Stock Performance relative to its Competitors
Vitanova Life Sciences's Comment on Competition and Industry Peers
Vitanova Life Sciences's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| VitaNova Life Sciences Corp | Dietary Supplement Segment 64.37 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
